Literature DB >> 81118

Influence of food on the bioavailability of drugs.

A Melander.   

Abstract

Food intake exerts a complex influence on the bioavailability of drugs. It may interfere not only with tablet disintegration, drug dissolution and drug transit through the gastrointestinal tract, but may also affect the metabolic transformation of drugs in the gastrointestinal wall and in the liver. Different food components can have different effects, and food may interact in opposite ways, even with drugs that are chemically related. Therefore, the net effect of food on drug bioavailability can be predicted only by direct clinical studies of the drug in question. As judged mainly from single meal, single dose studies, food intake enhances the bioavailability of several different drugs, such as propranolol, metoprolol, hydrallazine, hydrochlorothiazide, canrenone (from spironolactone), nitrofurantoin, erythromycin (stearate), dicoumarol, phenytoin and carbamazepine, but reduces that of drugs such as isoniazid, rifampicin, tetracycline, penicillin and ampicillin, while having no consistent effect on the bioavailability of metronidazole, oxazepam, melperone, propylthiouracil, sulphasomidine and sulphonylureas. For some drugs such as digoxin and paracetamol, the rate but not the extent of absorption is reduced. Food may enhance bioavailability even though, or rather because, the rate of gastric emptying is reduced; this is apparently the case with hydrochlorothiazide and nitrofurantoin. The food induced enhancement of bioavailability of propranolol, metoprolol and hydrallazine is probably due to reduced first pass metabolism of these drugs, while food induced improvement of drug dissolution may explain the enhanced bioavailability of carbamazepine, canrenone, dicoumarol and phenytoin. An increased gastrointestinal pH may be in part the cause of the food induced reduction of the bioavailability of drugs such as isoniazid and tetracycline. In addition to single meal effects, repeated intake of protein-rich meals enhance, while carbohydrate-rich meals reduce, the rate of oxidation of antipyrine and theophylline. Moreover, intake of charcoal broiled meat markedly accelerates the oxidation of phenacetin and variably accelerates elimination of theophylline. Thus, food and its components and contaminants may have both short and long term effects on both the absorptive and biotransformation processes influencing systemic availability of drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81118     DOI: 10.2165/00003088-197803050-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  61 in total

1.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

2.  Food and the handling of drugs.

Authors: 
Journal:  Br Med J       Date:  1977-05-21

3.  Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease.

Authors:  A Melander; G Kahlmeter; C Kamme; B Ursing
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

4.  Antimicrobial activity and human pharmacology of amoxicillin.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Effects of antacids on gastrointestinal absorption of isoniazid in rat and man.

Authors:  A Hurwitz; D L Schlozman
Journal:  Am Rev Respir Dis       Date:  1974-01

Review 6.  Factors affecting gastrointestinal absorption of drugs.

Authors:  R R Levine
Journal:  Am J Dig Dis       Date:  1970-02

7.  Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste.

Authors:  R J White; D A Chamberlain; M Howard; T W Smith
Journal:  Br Med J       Date:  1971-02-13

8.  Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.

Authors:  C Bogentoft; I Carlsson; G Ekenved; A Magnusson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

9.  Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

10.  Destruction of chlorpromazine during absorption in the rat in vivo and in vitro.

Authors:  S H Curry; A D'Mello; G P Mould
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

View more
  82 in total

1.  Application of a biomagnetic measurement system (BMS) to the evaluation of gastrointestinal transit of intestinal pressure-controlled colon delivery capsules (PCDCs) in human subjects.

Authors:  Z Hu; S Mawatari; N Shibata; K Takada; H Yoshikawa; A Arakawa; Y Yosida
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media.

Authors:  Edmund S Kostewicz; Ulrich Brauns; Robert Becker; Jennifer B Dressman
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

3.  Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast.

Authors:  J I Schwartz; D J Margolskee; T D Bjornsson; V C Williams; J Y Hsieh; C C Lin; J D Rogers
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

4.  Effect of food on the bioavailability of SDZ DJN 608, an oral hypoglycemic agent, from a tablet and a liquid-filled capsule in the dog.

Authors:  F L Tse; D Labbadia; K Habucky; A Karara; S Au
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 5.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

6.  Milk and yoghurt do not impair the absorption of ofloxacin.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 7.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

8.  Metabolism of pantethine in cystinosis.

Authors:  C T Wittwer; W A Gahl; J D Butler; M Zatz; J G Thoene
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Physiological and pharmacological variability in estimated hepatic blood flow in man.

Authors:  T K Daneshmend; L Jackson; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

10.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.